Similar to the case of other tumors, in PCa, the level of m6A is significantly higher than that in normal prostate tissue, and the expression of some m6A regulators, including FTO, METTL3, IGF2BP2, and YTHDF2, is downregulated (22–26). The gene discussed is FTO; the disease is posterior cortical atrophy.